Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Adam E. Haynes"'
Publikováno v:
ESMO Open
Background Whether patients with excellent and reduced performance status (PS) derive different net clinical benefit from novel anticancer systemic therapies on clinical trials is unclear. Materials and methods A systematic review was conducted of ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd7d0fcc8506a7b75f779a86f7553b0d
https://pubmed.ncbi.nlm.nih.gov/29209535
https://pubmed.ncbi.nlm.nih.gov/29209535
Autor:
Kevin Imrie, Fulvia Baldassarre, Matthew C. Cheung, Adam E. Haynes, Donna E. Reece, C.T. Kouroukis
Publikováno v:
Clinical Oncology. 26:110-119
Aims Bortezomib (Velcade™, PS-341), a first-in-class proteasome inhibitor, has been extensively studied either alone or in combination with other agents for the treatment of multiple myeloma. We created a provincial guideline for the use of bortezo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a92c7b46ed70ba379e2378583798b10
https://doi.org/10.1016/j.clon.2013.11.022
https://doi.org/10.1016/j.clon.2013.11.022
Autor:
Lisa K. Hicks, Harriet Bering, Adam E. Haynes, Judith Kleinerman, Alice Ma, Brigitta U. Mueller, Mark Crowther, Kenneth R. Carson, Vishal Kukreti, Lawrence A. Solberg, Marcelo C. Pasquini, Ravindra Sarode, Sarah H. O'Brien
Publikováno v:
Hematology. 2013:9-14
Choosing Wisely® is a medical stewardship and quality improvement initiative led by the American Board of Internal Medicine Foundation in collaboration with leading medical societies in the United States. The ASH is an active participant in the Choo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4d640681ee9664f1630439506c3023
https://doi.org/10.1182/asheducation-2013.1.9
https://doi.org/10.1182/asheducation-2013.1.9
Autor:
Sohail Mulla, Kelvin K. W. Chan, Susan Mirabi, Kendra Christiansen, Maureen E. Trudeau, Adam E. Haynes, Alexandra Chambers
Publikováno v:
Journal of Clinical Oncology. 36:42-42
42 Background: In Canada, through the pan-Canadian Oncology Drug Review (pCODR) process, CADTH conducts evaluations of clinical, economic, and patient evidence on cancer drugs to provide public reimbursement recommendations. The pCODR Expert Review C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0786b833f4ab7f7d99b5e9df6cd2ecfc
https://doi.org/10.1200/jco.2018.36.30_suppl.42
https://doi.org/10.1200/jco.2018.36.30_suppl.42
Autor:
Alexandra Chambers, Valerie McDonald, Missale Tiruneh, Catherine Moltzan, Kristina Ellis, Stephanie Ross, Adam E. Haynes, Maureen E. Trudeau
Publikováno v:
Journal of Clinical Oncology. 36:100-100
100 Background: In Canada, the Canadian Agency for Drugs and Technologies in Health’s pERC makes reimbursement recommendations for cancer drugs based on pCODR reviews of best available evidence, which in some circumstances, is from Phase II NRTs. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4bbe6f6716cae3f52b8d1f484696c9f
https://doi.org/10.1200/jco.2018.36.30_suppl.100
https://doi.org/10.1200/jco.2018.36.30_suppl.100
Publikováno v:
Journal of Thoracic Oncology. 1:591-601
BackgroundThis clinical practice guideline, based on a systematic review, was developed to determine which chemotherapeutic agents (or combinations of agents) show the highest response rates, improved survival, quality of life, or symptom control in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b812145c26dd6570773c42795dfc673f
https://doi.org/10.1016/s1556-0864(15)30366-x
https://doi.org/10.1016/s1556-0864(15)30366-x
Autor:
Matthew C. Cheung, Adam E. Haynes, Adrienne Stevens, Ralph M. Meyer, Kevin Imrie, null The members of the hematology disea
Publikováno v:
Leukemia & Lymphoma. 47:967-977
Radioimmunoconjugates are radioisotope-bound monoclonal antibodies that target radiation specifically to sites of lymphoma involvement. Initial studies of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma (NHL) have suggested benefit in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a934ddd18c7ea2ab404333a6241cb375
https://doi.org/10.1080/10428190600572582
https://doi.org/10.1080/10428190600572582
Autor:
Lisa K. Hicks, Anita Rajasekhar, Brigitta U. Mueller, Marcelo C. Pasquini, Judith Kleinerman, Julie A. Panepinto, Sarah H. O'Brien, Ravindra Sarode, Adam E. Haynes, William A. Wood, Alice Ma, Harriet Bering, Kenneth R. Carson, Vishal Kukreti
Publikováno v:
Blood. 124(24)
Choosing Wisely® is a medical stewardship initiative led by the American Board of Internal Medicine Foundation in collaboration with professional medical societies in the United States. The American Society of Hematology (ASH) released its first Cho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb92ba62f7ccef8a3ff631a3d3f2c3a6
https://pubmed.ncbi.nlm.nih.gov/25472968
https://pubmed.ncbi.nlm.nih.gov/25472968
Publikováno v:
Blood. 128:5992-5992
Background: Hodgkin lymphoma (HL) and aggressive non-Hodgkin lymphoma (NHL) both have relatively high curative-potential with contemporary treatment strategies. Despite this, a substantial number of patients will relapse, and a principal objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c79251461a25b42d743cc171dee4c2b
https://doi.org/10.1182/blood.v128.22.5992.5992
https://doi.org/10.1182/blood.v128.22.5992.5992
Autor:
Brian M. Wong, Adam E. Haynes, Bryan B. Franco, Matthew C. Cheung, Simron Singh, Laavanya Dharmakulaseelan
Publikováno v:
Journal of Clinical Oncology. 34:203-203
203 Background: In 2001, the Institute of Medicine (IOM) outlined imperatives to improve quality of care. Quality improvement (QI) has since become essential to cancer care but barriers still exist to the publication of and participation in QI initia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::528ef4d4b6078b7843c0a044f8658c7d
https://doi.org/10.1200/jco.2016.34.7_suppl.203
https://doi.org/10.1200/jco.2016.34.7_suppl.203